150 Million Rubles Grant

13 September 2021
PetrSU won a grant for development of a unique scientific installation for Arctic biomedicine.

PetrSU won a grant for development of a unique scientific installation for Arctic biomedicine.

A unique scientific installation, built within the cooperation of PetrSU between K-SkAI company (Skolkovo resident), got a development grant in the amount of 150 million rubles.

The leading universities of Russia competed for the scientific grant which represents a subsidy for development of material and technical infrastructure.

Here at PetrSU we have a strong team of the Institute of Medicine, which has repeatedly proved its leadership positions as a research team, a team of professional clinicians. By solving large-scale scientific problems that cover several areas and priorities of scientific and technological development, we are will be able to transition to advanced digital, intelligent production technologies, to create systems for processing large amounts of data with machine learning and artificial intelligence technologies, to implement the transition to personalized medicine, high-tech healthcare and health-preserving technologies.

  • Anatoly Voronin, PetrSU Rector, Professor

Our cooperation with PetrSU is focused on joint activities and project development in the field of artificial intelligence technologies. With no doubt, it helps to expand the possibilities of Webiomed platform, to form a stable territorial and industrial partnership between a scientific organization and a technological company.

  • K-SkAI Chief Executive Office Roman Novitsky

The unique scientific installation is the first multicomponent software and hardware complex for biomedical purposes used in the Arctic zone of Russia. It represents a unified research platform for the comprehensive study of humans following the “molecule-cell-tissue-organ-organism-environment” system. The platform will perform the following functions:

  • Automated collection, storage, separation of research and clinical biomedical data;
  • Data analysis on the basis of algorithms of artificial intelligence and predictive analytics;
  • Introduction of innovative technologies into research and educational activities, practical medicine and real clinical practice;
  • Establishment of research and educational medical cluster.

The unique scientific installation, in close cooperation between Russian and foreign partners, conducts research and development in the field of molecular genetics, oncoimmunology, neurophysiology, bioregulation, cell biology, pharmacology, epidemiology, cardiology, perinatal medicine and bioinformatics, combining the achievements of fundamental medicine and real clinical practice, meeting modern challenges of scientific and technological progress.

The installation is integrated with the AI-enabled predictive analytics and risk assessment in healthcare Webiomed, which allows using artificial intelligence methods to analyze data and determine the risks of developing diseases, as well as suspected diseases and complications.

Webiomed is the first Russian platform that provides AI-enabled predictive analytics and risk assessment in healthcare which successfully passed independent clinical tests and registered by Roszdravnadzor as a medical device. At the moment, the system includes 14 diseases; it assesses the risks of their development or aggravation. The most significant results of the platform development are found in predictive analytics of the cardiovascular system diseases, respiratory diseases, COVID-19, diabetes mellitus, oncological and orphan diseases, in prenatal medicine.

K-SkAI is a Skolkovo resident company, the developer of Webiomed platform, AI-enabled predictive analytics and risk assessment in healthcare.

PetrSU is the largest multidisciplinary classical university of the northern European Russia, the Flagship University of the Republic of Karelia. Within the framework of international cooperation, PetrSU interacts with foreign organizations in the field of biomedicine. Such organizations include Tufts University (Boston, USA), University of Eastern Finland (Kuopio, Finland), Tampere University Hospital (Tampere, Finland), Finnish Institute for Occupational Health (FIOH, Oulu, Finland).

Research and development on the platform are supported by the grants of the Russian Science Foundation, Federal Target Programs, Presidential and Governmental grants, as well as the RAS Program “Fundamental Sciences in Medicine”.

 Institute of Medicine

Theoretical building (ul. Krasnoarmeiskaia, 31), room 349

(814-2) 78-15-50


Last news